Terminated PHASE4 INTERVENTIONAL NCT00164099

The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study

Sponsor: Beth Israel Medical Center

Conditions Bacteremia Cystitis Enterocolitis, Pseudomembranous Pneumonia Surgical Wound Infection

Interventions Synbiotic 2000

Updated 5 times since 2017 Last updated: Oct 30, 2007 Started: Nov 30, 2005 Completion: Jun 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Patients would not take product

Other terminated trials from Beth Israel Medical Center

See all terminations from Beth Israel Medical Center

Other Bacteremia trials with similar outcome

Browse all Bacteremia trials

Listed as NCT00164099, this PHASE4 trial focuses on Bacteremia and Cystitis and remains terminated or withdrawn. Sponsored by Beth Israel Medical Center, it has been updated 5 times since 2005, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beth Israel Medical Center

Data source: Beth Israel Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States